Sanofi is back with its second pact of the day, this time announcing a licensing deal for a South Korean biotech’s antibody ...

A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look ...

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

Looking for top-rated stocks to buy now? Recent analyst updates highlight three companies that have earned Strong Buy ratings ...

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...